SANTA MONICA, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its third quarter 2020 financial results after the financial markets close on Thursday November 12, 2020.
News Ticker
- [ October 9, 2026 ] Four new life sciences departments showcase USC Dornsife’s strengths in biology Los Angeles Biotech News
- [ October 9, 2026 ] Diabetes Sales Associate Los Angeles Biotech Jobs
- [ October 9, 2026 ] Strongpoint Partners Platform Grows with Addition of Hilde Minkel & Associates Los Angeles Biotech News
- [ October 9, 2026 ] HICE and Gabeo.ai Join Forces to Advance Transparency in Healthcare Risk Contracts Los Angeles Biotech News
- [ October 8, 2026 ] SELENA GOMEZ ANNOUNCES LEON BRIDGES AND BELLA KAY AS ENTERTAINMENT FOR THE FOURTH ANNUAL RARE IMPACT FUND BENEFIT Los Angeles Biotech News
Copyright © 2026 Biotech Networks, LLC
